Agranulocytosis and Rash pustular

Summary:

Rash pustular is found among people with Agranulocytosis, especially for people who are female, 10-19 old.

The study analyzes which people have Rash pustular with Agranulocytosis. It is created by eHealthMe based on reports of 12 people who have Agranulocytosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,321 drugs and 3,597 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

What is Rash pustular?

Rash pustular (redness with pustules) is found to be associated with 701 drugs and 1,015 conditions by eHealthMe. Check the latest studies of Rash pustular.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

12 people who have Agranulocytosis and Rash Pustular are studied.

Would you have Rash pustular when you have Agranulocytosis?

Gender of people who have Agranulocytosis and experienced Rash Pustular *:

female: 90.91 %
male: 9.09 %

Age of people who have Agranulocytosis and experienced Rash Pustular *:

Common co-existing conditions for these people *:

Osteosarcoma Metastatic (a cancerous (malignant) bone tumour can spreads to other parts): 6 people, 50.00%
Pain: 4 people, 33.33%
Rashes (redness): 1 person, 8.33%
Nausea (feeling of having an urge to vomit): 1 person, 8.33%
Metastases To Bone (cancer spreads to bone): 1 person, 8.33%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 8.33%
Cough: 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%

Common drugs taken by these people *:

Common symptoms for these people *:

Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 6 people, 50.00%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 3 people, 25.00%
White Blood Cell Count Decreased: 1 person, 8.33%
Suicidal Ideation: 1 person, 8.33%
Red Blood Cell Count Decreased: 1 person, 8.33%
Rash Papular (redness with papule): 1 person, 8.33%
Neutrophil Percentage Decreased: 1 person, 8.33%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 1 person, 8.33%
Drug Toxicity: 1 person, 8.33%
Depression: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Rash pustular?

- Check whether Rash pustular is associated with a drug or a condition

Related publications that referenced our studies

Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .

Related studies:

Treatments, associated drugs and conditions:

Agranulocytosis (213,267 reports)
Rash pustular (9,746 reports)

All the drugs that are associated with Rash pustular:

Rash pustular (701 drugs)

All the conditions that are associated with Rash pustular:

Rash pustular (1,015 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Rash pustular and Agranulocytosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.